Roundtable: USA – How Generics Win U.S. Pharma Cases, and What Cases Tell Brands to Do Differently
Drawing on recent U.S. pharmaceutical patent litigation cases, this roundtable examines how generic manufacturers are successfully challenging branded patent portfolios and the key legal and strategic factors driving their victories. Participants will explore what these outcomes reveal about vulnerabilities in innovator patent strategies and the practical lessons for brand protection and enforcement success in the U.S.